This is a 24-week randomized double-blind, parallel-group, multi-center, placebo-controlled
study of tesaglitazar (0. 5 mg and 1 mg) given as add-on therapy to sulphonylurea in patients
with type 2 diabetes, not adequately controlled on optimized sulphonylurea treatment and on
diet/lifestyle advice during the titration and run-in period. The study comprises a 2-week
enrollment period, 6 week placebo metformin titration period, 2-week single-blind run-in
period, followed by a 24-week double blind treatment period and a 3-week follow-up period
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Research Site, Adelaide, Australia
Research Site, Brisbane, Australia
Research Site, Cairns, Australia
Research Site, Geelong, Australia
Research Site, Melbourne, Australia
Research Site, Perth, Australia
Research Site, Sydney, Australia
Research Site, Tasmania, Australia
Research Site, Angers, France
Research Site, Hyeres, France
Research Site, La Garde, France
Research Site, La Seyne Sur Mer, France
Research Site, Laval, France
Research Site, Le Brusc, France
Research Site, Le Lavandou, France
Research Site, Montrevault, France
Research Site, Paris, France
Research Site, Saint-Cyr, France
Research Site, Six Fours Les Plages, France
Research Site, Tierce, France
Research Site, Toulon, France
Research Site, Ashkelon, Israel
Research Site, Haifa, Israel
Research Site, Holon, Israel
Research Site, Jerusalem, Israel
Research Site, Rishon-Lezion, Israel
Research Site, Tel Aviv, Israel
Research Site, Tel Hashomer, Israel
Research Site, Zefat, Israel
Research Site, Seoul, Korea, Republic of
Research Site, Suwon, Korea, Republic of
Research Site, Bergen, Norway
Research Site, Elverum, Norway
Research Site, Enebakk, Norway
Research Site, Fredrikstad, Norway
Research Site, Gamle Fredrikstad, Norway
Research Site, Hamar, Norway
Research Site, Haugesund, Norway
Research Site, Hurdal, Norway
Research Site, Inderøy, Norway
Research Site, Lena, Norway
Research Site, Levanger, Norway
Research Site, Oslo, Norway
Research Site, Rud, Norway
Research Site, Sedsmokorset, Norway
Research Site, Soerumsand, Norway
Research Site, Stavanger, Norway
Research Site, Manila, Philippines
Research Site, Marikina City, Philippines
Research Site, Pasig City, Philippines
Research Site, Cape Town, South Africa
Research Site, Chatsworth, South Africa
Research Site, Gauteng, South Africa
Research Site, Pretoria, South Africa
Research Site, Alzira (Valencia), Spain
Research Site, Barcelona, Spain
Research Site, Guissona (Lleida), Spain
Research Site, Madrid, Spain
Research Site, San Sebastian de los Reyes ( Madrid), Spain
Research Site, San Vicente de Raspeig (Alicante), Spain
Research Site, Valencia, Spain
Research Site, Aberdeen, United Kingdom
Research Site, Barnsley, United Kingdom
Research Site, Bath, United Kingdom
Research Site, Belfast, United Kingdom
Research Site, Birmingham, United Kingdom
Research Site, Cardiff, United Kingdom
Research Site, Coventry, United Kingdom
Research Site, Dundee, United Kingdom
Research Site, East Sussex, United Kingdom
Research Site, Edinburgh, United Kingdom
Research Site, Glasgow, United Kingdom
Research Site, Leeds, United Kingdom
Research Site, Liverpool, United Kingdom
Research Site, London, United Kingdom
Research Site, Manchester, United Kingdom
Research Site, Shrewsbury, United Kingdom
Research Site, Surrey, United Kingdom
Research Site, West Midlands, United Kingdom
Research Site, Wiltshire, United Kingdom
Research Site, Wrexham, United Kingdom
Research Site, Hanoi, Vietnam
Research Site, Ho Chi Minh, Vietnam
Research Site, Dublin, Ireland, United Kingdom